GLP-1 Medications Show Promise in Reducing Stroke and Heart Risks
Recent studies highlight the cardiovascular benefits of GLP-1 medications, such as Ozempic and Mounjaro, originally designed for managing type 2 diabetes. These medications are gaining attention not only for their effectiveness in weight management but also for their potential to reduce the risks associated with heart disease and stroke. Research published in BMJ Medicine indicates…
